Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine (rVSVΔG-ZEBOV-GP)
Clinical trial NCT02283099 · COMPLETED
Trial details
- NCT number
- NCT02283099
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2015-11-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.